AGTR1 and sarcopenia: Our study provides evidence for the hierarchical relationship between AT1 receptor signaling and C1q/Wnt-β-catenin signaling in promoting aging-related functional decline, and indicates that AT1 receptor blockade emerges as a preventive strategy against geriatric sarcopenia and frailty.